• Department of Cardiac Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150010, P.R.China;
LIU Hongyu, Email: hyliu1963@163.com
Export PDF Favorites Scan Get Citation

Heart failure is a global problem that occurs in 38 million patients worldwide, and the number is dramatically increasing in elderly society. Meanwhile, heart dysfunction is also the most common disease among hospitalized patients more than 65 years, especially in high-income countries. Approximately, one million patients are hospitalized because of heart failure in the world every year. Drug therapy is currently the most popular treatment for heart failure in clinic, however, the effects are limited. Therefore, exploring novel treatment strategies gradually becomes a focus not only in basic but also in clinical research.

Citation: GUO Rui, LIU Hongyu. Update on nonpharmacologic treatment for heart failure. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2017, 24(5): 390-395. doi: 10.7507/1007-4848.201605010 Copy

  • Previous Article

    Anti-apoptosis effect and mechanism of heme oxygenase-1 on lung injury after cardiopulmonary bypass
  • Next Article

    Surgical effect of low birth weight children with congenital heart disease